TBPH · Company research
Theravance Biopharma, Inc. (TBPH): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableOther
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 17.03 | $873,281,370 | 585180370.00 | 8.2833392511450023 | — | — | 49.3407181196677778 | 3.0051596729457594 | 11.9172118888085265 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.